Researchers at IIT Roorkee developed Compound 3b to restore Meropenem's antibiotic power Compound 3b targets Klebsiella pneumoniae, a WHO-designated top-priority drug-resistant pathogen The compound blocks bacterial enzymes that destroy antibiotics and is safe for human cells
